Penicillium marneffei is the most important thermal dimorphic fungus causing respiratory, skin and systemic mycosis in Southeast Asia. [1] [2] [3] About 8% of AIDS patients in Hong Kong are infected with P. marneffei. Clinically, penicilliosis manifests as a systemic febrile illness, which results from intracellular infection of the reticuloendothelial cells by the yeast phase of the fungus. Besides HIV-positive patients, P. marneffei infections have been reported in other immunocompromised patients, such as renal transplant recipients, patients with systemic lupus erythematosus and patients who are receiving corticosteroid therapy. 4, 5 Here, we describe the first case of P. marneffei infection in a bone marrow transplant recipient.
A 57-year-old Chinese man was admitted to hospital in March 2004 because of progressive shortness of breath for 1 month. He was diagnosed with IgA myeloma (stage IIIA) in July 2000 and received an allogeneic peripheral blood stem cell (HLA-matched) transplant in December 2000, using fludarabine and total body irradiation as conditioning. Ciprofloxacin, acyclovir and fluconazole were given as the antimicrobial prophylaxis. 6 Engraftment occurred on day 18. However, the transplant was complicated by acute graft-versus-host disease (onset day 34), Clostridium difficile colitis (day 36), cytomegalovirus colitis (day 38), chronic graft-versus-host disease (onset day 163) and herpes zoster (day 266). At 1 year after his transplant, he developed bronchiolitis obliterans organizing pneumonia (BOOP) confirmed by open-lung biopsy and was commenced on oral prednisolone (40 mg daily), which was gradually tailed off and stopped 9 months later. At 2 months before this admission, he was restarted on oral prednisolone (30 mg daily) because of worsening of BOOP. His condition was further complicated by corticosteroidinduced diabetes mellitus requiring oral hypoglycaemic agents. On admission, he was afebrile. Chest radiograph revealed bilateral diffuse ground glass opacities. Culture of the bronchoalveolar lavage fluid only resulted in only a scanty growth of Candida albicans. The dose of prednisolone was increased to 40 mg twice daily to control the BOOP.
On day 7 after admission, he developed numbness in his hands and feet of a glove and stocking distribution. Magnetic resonance imaging revealed epidural myelomatous infiltrates involving the right cervical canal, with paravertebral extension encasing the exiting nerve root from right C7 to T1. On day 18, he developed fever, chills and rigours. Examination showed an oral temperature of 39.91C and a small subcutaneous abscess on the tip of the left index finger. Intravenous piperacillin/tazobactam was commenced. Blood and abscess pus cultures were positive for methicillin-sensitive Staphylococcus aureus. Piperacillin/ tazobactam was stopped and cloxacillin commenced. The fever and other symptoms subsided.
On day 27 after admission, he again developed fever and septic shock while still on intravenous cloxacillin. Examination showed an oral temperature of 38.51C, tachycardia of 102 beats/min and a blood pressure of 84/43 mmHg. There were no localizing signs. The haemoglobin was 14.3 g/dl, total leukocyte count 2.8 Â /l. The serum urea was 17.9 mmol/l, creatinine 109 mmol/l, albumin 20 g/l, globulin 34 g/l, bilirubin 54 mmol/l, alkaline phosphatase 255 U/l, alanine aminotransferase 531 U/l and aspartate aminotransferase 313 U/l. C-reactive protein was 3.72 mg/dl. Blood cultures (BAC-TEC 9240 blood culture system, Becton Dickinson, MD, USA) on days 22, 27 and 29 were positive for a fungus that demonstrated thermal dimorphism. When cultured on Sabouraud agar at 251C, the colonies were mycelial in nature and produced a diffusible red pigment. Microscopically, the mycelia bore numerous penicilli characteristic of other Penicillium species. When cultured at 371C, yeastlike colonies were formed without pigment production. The fungus was identified as P. marneffei. Intravenous amphotericin B (1 mg/kg/day) was commenced. Despite treatment, his condition deteriorated and he died on day 44 with multi-organ failure.
Mp1p antibody and antigen profiles were determined using serum samples obtained during the period of hospitalization and stored serum samples obtained during previous hospitalizations (Figure 1) . 7, 8 The Mp1p IgG antibody titre was o1 : 800 at admission, and became positive on day 18 post-admission (4 days before blood culture was positive for P. marneffei and 9 days before the presence of Mp1p antigenaemia), reached a peak of 1:6400 on day 25, and gradually decreased to o1 : 800 on day 42. The Mp1p antigen titre was o1 : 80 at admission, became positive on day 27 post-admission, reached a peak of 1 : 640 on day 29 and decreased to o1:80 on day 32. Similar to our previously reported case of penicilliosis in a patient with Waldenstrom's macroglobulinaemia, 9 P. marneffei infection in the present case probably occurred due to reactivation of latent infection. The lymphocyte count of the present patient decreased gradually from 41 Â 10 9 /l to o0.5 Â 10 9 /l during the 60 days before admission as a result of corticosteroid treatment of BOOP. Interestingly, the patient with Waldenstrom's macroglobulinaemia and the patient in the present report both had systemic bacterial infections, Escherichia coli septic arthritis in the patient with Waldenstrom's macroglobulinaemia and S. aureus bacteraemic abscess in the present case, shortly before the manifestation of their P. marneffei infections. This is because when the immune system of a patient is heavily suppressed, the first infective complications are often pyogenic bacterial infections, due to the rapid replication of the bacteria. Pyogenic bacterial infections are followed by reactivation of other latent infections, such as penicilliosis as occurred in these two cases.
The rise of the Mp1p antibody titre before the presence of P. marneffei fungaemia and Mp1p antigenaemia is in line with reactivation of a latent infection. In our previous study, the classical picture of change in antigen and antibody titres for primary infection was observed, in that Mp1p antigenaemia appeared before the appearance of Mp1p antibody. 10 In contrast to what was observed in the previous study, the Mp1p antibody became detectable 4 days before the blood culture was positive for P. marneffei and 9 days before the presence of Mp1p antigenaemia. We speculate that this was due to past P. marneffei infection and memory immunity in the patient. When P. marneffei reactivated because of a decrease in the lymphocyte count, the antibody response quickly developed to detectable levels a few days before P. marneffei was recovered from blood, and the development of Mp1p antigenaemia. 
